Physician

Kimberly Uhles Hurvitz, M.D.

According to 2025 Medicare claims, Kimberly Hurvitz, M.D. (NPI: 1497810402) practices dermatology in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is KIMBERLY UHLES HURVITZ, MD INC (NPI: 1144594706; TIN: 45-4510197) and primary practice location at 93105-4301.

Hurvitz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 715 traditional Medicare patients, billed 11,067 HCPCS/CPT codes, and received $887,727 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 509 prescription claims across 236 beneficiaries totaling $67,778 in drug costs, led by Otezla (Apremilast). Open Payments data shows 4 records totaling $98. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $297,677 and ending at $887,727. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $36,682 and ending at $67,778. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	784	7,217	$297,677
2016	666	6,274	$282,547
2017	884	9,063	$406,767
2018	1,033	11,124	$425,892
2019	1,012	9,799	$361,487
2020	778	7,347	$261,696
2021	893	8,206	$322,105
2022	1,049	9,877	$421,905
2023	799	7,544	$408,745
2024	715	11,067	$887,727

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	132	371	$36,682
2016	160	414	$45,047
2017	193	402	$26,953
2018	254	540	$33,298
2019	276	610	$38,112
2020	297	642	$44,069
2021	288	608	$33,648
2022	258	537	$34,041
2023	188	399	$25,646
2024	236	509	$67,778

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17004	Destruction of precancer skin growth, 15 or more growths	381	578	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	525	849	$90
11102	Biopsy of related skin growth, first growth	338	471	$67
17000	Destruction of precancer skin growth, 1 growth	341	442	$36
88305	Pathology examination of tissue using a microscope, intermediate complexity	348	794	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	11	330	$50,293
Fluocinonide	Fluocinonide	66	1,965	$2,227
Fluorouracil	Fluorouracil	26	696	$1,613
Ketoconazole	Ketoconazole	55	1,895	$1,091
Valacyclovir	Valacyclovir Hcl	33	578	$1,060

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$98	SUN PHARMACEUTICAL INDUSTRIES INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kimberly Uhles Hurvitz, M.D.?

Tedicare shows public-source Medicare data for Kimberly Uhles Hurvitz, M.D. (NPI 1497810402), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kimberly Uhles Hurvitz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kimberly Uhles Hurvitz, M.D.?

Kimberly Uhles Hurvitz, M.D. is linked to KIMBERLY UHLES HURVITZ, MD INC (billing NPI 1144594706) in the available physician profile data.

Does Kimberly Uhles Hurvitz, M.D. have Open Payments data?

Kimberly Uhles Hurvitz, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.